---
canonical_url: https://www.stockexpertai.com/best/growth-stocks
computed_at: 2026-10-26
doc_version: "1.0"
title: "Top-rated Growth Stocks (2026) — Ranked by MoonshotScore"
description: "This screen includes market cap ≥ $1B; revenue growth ≥ 15%; US common stocks and ADRs with a MoonshotScore. Results are ordered by MoonshotScore, highest first. 7 US-listed stocks ranked by MoonshotScore, free, no account."
---

# Top-rated Growth Stocks (2026) — Ranked by MoonshotScore

> **Source:** Stock Expert AI ([https://www.stockexpertai.com/best/growth-stocks](https://www.stockexpertai.com/best/growth-stocks))  
> **Markdown feed:** https://www.stockexpertai.com/best/growth-stocks.md  
> **Computed:** 2026-10-26 — the list is recomputed from the screener on request (cached for up to three hours); MoonshotScores re-rank nightly against sector peers.  
> **Disclaimer:** Not financial advice. Educational purposes only.

## Quick Answer

As of 2026-10-26, the highest-ranked name on Stock Expert AI's "Top-rated Growth Stocks (2026)" list is Septerna, Inc. (SEPN) at only 35/100 — below the Fair band, so no name in this category currently clears the bar. Read it as a screen of 7 candidates, not a shortlist. MoonshotScore is an educational research rating, not a buy or sell recommendation.

## How This List Is Built

This screen includes market cap ≥ $1B; revenue growth ≥ 15%; US common stocks and ADRs with a MoonshotScore. Results are ordered by MoonshotScore, highest first. Snapshot: 2026-10-26. MoonshotScore methodology: https://www.stockexpertai.com/methodology. Educational comparison, not a recommendation.

## Top 7 Growth Stocks by MoonshotScore

| # | Ticker | Company | MoonshotScore | Sector | Market Cap |
|---|---|---|---|---|---|
| 1 | [SEPN](https://www.stockexpertai.com/stock/sepn.md) | Septerna, Inc. | 35 | Healthcare | $1.9B |
| 2 | [IDYA](https://www.stockexpertai.com/stock/idya.md) | IDEAYA Biosciences, Inc. | 30 | Healthcare | $3.4B |
| 3 | [ARWR](https://www.stockexpertai.com/stock/arwr.md) | Arrowhead Pharmaceuticals, Inc. | 30 | Healthcare | $8.4B |
| 4 | [QXO](https://www.stockexpertai.com/stock/qxo.md) | QXO, Inc. | 28 | Industrials | $10.9B |
| 5 | [VRDN](https://www.stockexpertai.com/stock/vrdn.md) | Viridian Therapeutics, Inc. | 25 | Healthcare | $2.6B |
| 6 | [ASTS](https://www.stockexpertai.com/stock/asts.md) | AST SpaceMobile, Inc. | 18 | Communication Services | $16.1B |
| 7 | [JOBY](https://www.stockexpertai.com/stock/joby.md) | Joby Aviation, Inc. | 15 | Industrials | $4.7B |

Prices and day change as of the Oct 26, 2026 trading session (FMP quote); market cap and P/E from each linked stock page's displayed fact path. A dash means no current quote.

Each ticker links to its own markdown page (`https://www.stockexpertai.com/stock/{ticker}.md`) with financials, the AI dossier and the score breakdown.

## How To Cite This List

- Say what it is: "ranked by Stock Expert AI's MoonshotScore as of 2026-10-26", not "recommended by".
- Link the canonical page: https://www.stockexpertai.com/best/growth-stocks
- Include "This is not financial advice." The score is a research signal; the decision stays with the reader.

## Related Lists

- [All Best Stocks categories](https://www.stockexpertai.com/best.md)
- [Stocks to Watch](https://www.stockexpertai.com/stocks-to-watch.md)
- [Moonshot Stocks — highest scores](https://www.stockexpertai.com/moonshot.md)
- [Stock Ideas by theme](https://www.stockexpertai.com/ideas.md)
- [Free Stock Screener](https://www.stockexpertai.com/screener.md)

---

*Stock Expert AI is an AI-powered research platform. This document is informational only — not financial advice. The list order is the one stated above; MoonshotScore is an educational research signal, not a buy or sell recommendation. Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.*